Healthcare Nanotechnology Industry Research Report 2025

Summary

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

According to APO Research, The global Healthcare Nanotechnology market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Healthcare Nanotechnology is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Healthcare Nanotechnology is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Healthcare Nanotechnology is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Healthcare Nanotechnology include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Healthcare Nanotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Nanotechnology.
The Healthcare Nanotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Healthcare Nanotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Healthcare Nanotechnology Segment by Company

Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Healthcare Nanotechnology Segment by Type

Nanomedicine
Nano Medical Devices
Nano Diagnosis
Others
Healthcare Nanotechnology Segment by Application

Anticancer
CNS Product
Anti-infective
Others
Healthcare Nanotechnology Segment by Application

Anticancer
CNS Product
Anti-infective
Others
Healthcare Nanotechnology Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Healthcare Nanotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Healthcare Nanotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Healthcare Nanotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Healthcare Nanotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Healthcare Nanotechnology by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Nanomedicine
2.2.3 Nano Medical Devices
2.2.4 Nano Diagnosis
2.2.5 Others
2.3 Healthcare Nanotechnology by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Anticancer
2.3.3 CNS Product
2.3.4 Anti-infective
2.3.5 Others
2.4 Assumptions and Limitations
3 Healthcare Nanotechnology Breakdown Data by Type
3.1 Global Healthcare Nanotechnology Historic Market Size by Type (2020-2025)
3.2 Global Healthcare Nanotechnology Forecasted Market Size by Type (2026-2031)
4 Healthcare Nanotechnology Breakdown Data by Application
4.1 Global Healthcare Nanotechnology Historic Market Size by Application (2020-2025)
4.2 Global Healthcare Nanotechnology Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Healthcare Nanotechnology Market Perspective (2020-2031)
5.2 Global Healthcare Nanotechnology Growth Trends by Region
5.2.1 Global Healthcare Nanotechnology Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Healthcare Nanotechnology Historic Market Size by Region (2020-2025)
5.2.3 Healthcare Nanotechnology Forecasted Market Size by Region (2026-2031)
5.3 Healthcare Nanotechnology Market Dynamics
5.3.1 Healthcare Nanotechnology Industry Trends
5.3.2 Healthcare Nanotechnology Market Drivers
5.3.3 Healthcare Nanotechnology Market Challenges
5.3.4 Healthcare Nanotechnology Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Healthcare Nanotechnology Players by Revenue
6.1.1 Global Top Healthcare Nanotechnology Players by Revenue (2020-2025)
6.1.2 Global Healthcare Nanotechnology Revenue Market Share by Players (2020-2025)
6.2 Global Healthcare Nanotechnology Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Healthcare Nanotechnology Head Office and Area Served
6.4 Global Healthcare Nanotechnology Players, Product Type & Application
6.5 Global Healthcare Nanotechnology Manufacturers Established Date
6.6 Global Healthcare Nanotechnology Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Healthcare Nanotechnology Market Size (2020-2031)
7.2 North America Healthcare Nanotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Healthcare Nanotechnology Market Size by Country (2020-2025)
7.4 North America Healthcare Nanotechnology Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Healthcare Nanotechnology Market Size (2020-2031)
8.2 Europe Healthcare Nanotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Healthcare Nanotechnology Market Size by Country (2020-2025)
8.4 Europe Healthcare Nanotechnology Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Healthcare Nanotechnology Market Size (2020-2031)
9.2 Asia-Pacific Healthcare Nanotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Healthcare Nanotechnology Market Size by Country (2020-2025)
9.4 Asia-Pacific Healthcare Nanotechnology Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Healthcare Nanotechnology Market Size (2020-2031)
10.2 South America Healthcare Nanotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Healthcare Nanotechnology Market Size by Country (2020-2025)
10.4 South America Healthcare Nanotechnology Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Healthcare Nanotechnology Market Size (2020-2031)
11.2 Middle East & Africa Healthcare Nanotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Healthcare Nanotechnology Market Size by Country (2020-2025)
11.4 Middle East & Africa Healthcare Nanotechnology Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Amgen
12.1.1 Amgen Company Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Revenue in Healthcare Nanotechnology Business (2020-2025)
12.1.4 Amgen Healthcare Nanotechnology Product Portfolio
12.1.5 Amgen Recent Developments
12.2 Teva Pharmaceuticals
12.2.1 Teva Pharmaceuticals Company Information
12.2.2 Teva Pharmaceuticals Business Overview
12.2.3 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology Business (2020-2025)
12.2.4 Teva Pharmaceuticals Healthcare Nanotechnology Product Portfolio
12.2.5 Teva Pharmaceuticals Recent Developments
12.3 Abbott
12.3.1 Abbott Company Information
12.3.2 Abbott Business Overview
12.3.3 Abbott Revenue in Healthcare Nanotechnology Business (2020-2025)
12.3.4 Abbott Healthcare Nanotechnology Product Portfolio
12.3.5 Abbott Recent Developments
12.4 UCB
12.4.1 UCB Company Information
12.4.2 UCB Business Overview
12.4.3 UCB Revenue in Healthcare Nanotechnology Business (2020-2025)
12.4.4 UCB Healthcare Nanotechnology Product Portfolio
12.4.5 UCB Recent Developments
12.5 Roche
12.5.1 Roche Company Information
12.5.2 Roche Business Overview
12.5.3 Roche Revenue in Healthcare Nanotechnology Business (2020-2025)
12.5.4 Roche Healthcare Nanotechnology Product Portfolio
12.5.5 Roche Recent Developments
12.6 Celgene
12.6.1 Celgene Company Information
12.6.2 Celgene Business Overview
12.6.3 Celgene Revenue in Healthcare Nanotechnology Business (2020-2025)
12.6.4 Celgene Healthcare Nanotechnology Product Portfolio
12.6.5 Celgene Recent Developments
12.7 Sanofi
12.7.1 Sanofi Company Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Revenue in Healthcare Nanotechnology Business (2020-2025)
12.7.4 Sanofi Healthcare Nanotechnology Product Portfolio
12.7.5 Sanofi Recent Developments
12.8 Merck & Co
12.8.1 Merck & Co Company Information
12.8.2 Merck & Co Business Overview
12.8.3 Merck & Co Revenue in Healthcare Nanotechnology Business (2020-2025)
12.8.4 Merck & Co Healthcare Nanotechnology Product Portfolio
12.8.5 Merck & Co Recent Developments
12.9 Biogen
12.9.1 Biogen Company Information
12.9.2 Biogen Business Overview
12.9.3 Biogen Revenue in Healthcare Nanotechnology Business (2020-2025)
12.9.4 Biogen Healthcare Nanotechnology Product Portfolio
12.9.5 Biogen Recent Developments
12.10 Stryker
12.10.1 Stryker Company Information
12.10.2 Stryker Business Overview
12.10.3 Stryker Revenue in Healthcare Nanotechnology Business (2020-2025)
12.10.4 Stryker Healthcare Nanotechnology Product Portfolio
12.10.5 Stryker Recent Developments
12.11 Gilead Sciences
12.11.1 Gilead Sciences Company Information
12.11.2 Gilead Sciences Business Overview
12.11.3 Gilead Sciences Revenue in Healthcare Nanotechnology Business (2020-2025)
12.11.4 Gilead Sciences Healthcare Nanotechnology Product Portfolio
12.11.5 Gilead Sciences Recent Developments
12.12 Pfizer
12.12.1 Pfizer Company Information
12.12.2 Pfizer Business Overview
12.12.3 Pfizer Revenue in Healthcare Nanotechnology Business (2020-2025)
12.12.4 Pfizer Healthcare Nanotechnology Product Portfolio
12.12.5 Pfizer Recent Developments
12.13 3M Company
12.13.1 3M Company Company Information
12.13.2 3M Company Business Overview
12.13.3 3M Company Revenue in Healthcare Nanotechnology Business (2020-2025)
12.13.4 3M Company Healthcare Nanotechnology Product Portfolio
12.13.5 3M Company Recent Developments
12.14 Johnson & Johnson
12.14.1 Johnson & Johnson Company Information
12.14.2 Johnson & Johnson Business Overview
12.14.3 Johnson & Johnson Revenue in Healthcare Nanotechnology Business (2020-2025)
12.14.4 Johnson & Johnson Healthcare Nanotechnology Product Portfolio
12.14.5 Johnson & Johnson Recent Developments
12.15 Smith & Nephew
12.15.1 Smith & Nephew Company Information
12.15.2 Smith & Nephew Business Overview
12.15.3 Smith & Nephew Revenue in Healthcare Nanotechnology Business (2020-2025)
12.15.4 Smith & Nephew Healthcare Nanotechnology Product Portfolio
12.15.5 Smith & Nephew Recent Developments
12.16 Leadiant Biosciences
12.16.1 Leadiant Biosciences Company Information
12.16.2 Leadiant Biosciences Business Overview
12.16.3 Leadiant Biosciences Revenue in Healthcare Nanotechnology Business (2020-2025)
12.16.4 Leadiant Biosciences Healthcare Nanotechnology Product Portfolio
12.16.5 Leadiant Biosciences Recent Developments
12.17 Kyowa Hakko Kirin
12.17.1 Kyowa Hakko Kirin Company Information
12.17.2 Kyowa Hakko Kirin Business Overview
12.17.3 Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology Business (2020-2025)
12.17.4 Kyowa Hakko Kirin Healthcare Nanotechnology Product Portfolio
12.17.5 Kyowa Hakko Kirin Recent Developments
12.18 Shire
12.18.1 Shire Company Information
12.18.2 Shire Business Overview
12.18.3 Shire Revenue in Healthcare Nanotechnology Business (2020-2025)
12.18.4 Shire Healthcare Nanotechnology Product Portfolio
12.18.5 Shire Recent Developments
12.19 Ipsen
12.19.1 Ipsen Company Information
12.19.2 Ipsen Business Overview
12.19.3 Ipsen Revenue in Healthcare Nanotechnology Business (2020-2025)
12.19.4 Ipsen Healthcare Nanotechnology Product Portfolio
12.19.5 Ipsen Recent Developments
12.20 Endo International
12.20.1 Endo International Company Information
12.20.2 Endo International Business Overview
12.20.3 Endo International Revenue in Healthcare Nanotechnology Business (2020-2025)
12.20.4 Endo International Healthcare Nanotechnology Product Portfolio
12.20.5 Endo International Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings